Home LiteratureArticle Details
PMID: 17502385 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972.

Infection and immunity ·Vol. 75 ·No. 8 ·2007-08-00 ·Pages 3688-95

Klemm P, Hancock V, Schembri MA

Abstract

暂无摘要

MeSH Terms
Adaptation, Physiological Bacteriuria/microbiology Escherichia coli/genetics,immunology,pathogenicity,physiology Escherichia coli Infections/microbiology Humans Symbiosis Urinary Bladder/microbiology Virulence Factors
Chemicals
Virulence Factors
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Klemm Per
Microbial Adhesion Group, Center for Biomedical Microbiology, BioCentrum-DTU, Technical University of Denmark, DK-2800 Lyngby, Denmark. pkl@biocentrum.dtu.dk
Hancock Viktoria
Schembri Mark A
References (74)
74 references, click to expand
  1. Theory of hydrokinetic clearance of bacteria from the urinary bladder. I. Effect of variations in bacterial growth rate.
    Invest Urol. 1975 May;12(6):468-72 PMID: 1120639
  2. Asymptomatic bacteriuria in schoolgirls. II. Differences in escherichia coli causing asymptomatic bacteriuria.
    Acta Paediatr Scand. 1975 May;64(3):432-6 PMID: 1098383
  3. Protective capacity of antibodies against Escherichia coli and K antigens.
    Infect Immun. 1977 Aug;17(2):286-9 PMID: 70410
  4. Asymptomatic bacteriuria in schoolgirls. VIII. Clinical course during a 3-year follow-up.
    J Pediatr. 1978 Feb;92(2):194-9 PMID: 340626
  5. Structural basis of the interaction of the pyelonephritic E. coli adhesin to its human kidney receptor.
    Cell. 2001 Jun 15;105(6):733-43 PMID: 11440716
  6. Pilot trial of bacterial interference for preventing urinary tract infection.
    Urology. 2001 Sep;58(3):339-44 PMID: 11549475
  7. Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis.
    J Urol. 2002 Jan;167(1):375-9 PMID: 11743359
  8. Virulence factors of uropathogens.
    Curr Opin Urol. 2002 Jan;12(1):33-8 PMID: 11753131
  9. Microbial minimalism: genome reduction in bacterial pathogens.
    Cell. 2002 Mar 8;108(5):583-6 PMID: 11893328
  10. Identification of target tissue glycosphingolipid receptors for uropathogenic, F1C-fimbriated Escherichia coli and its role in mucosal inflammation.
    J Biol Chem. 2002 May 17;277(20):18198-205 PMID: 11877427
  11. Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection.
    Lancet. 1976 Sep 4;1(7984):490-2 PMID: 74461
  12. Adhesion to normal human uroepithelial cells of Escherichia coli from children with various forms of urinary tract infection.
    J Pediatr. 1978 Sep;93(3):398-403 PMID: 357693
  13. Glycolipid receptors for uropathogenic Escherichia coli on human erythrocytes and uroepithelial cells.
    Infect Immun. 1981 Dec;34(3):920-9 PMID: 7037645
  14. Virulence properties of Escherichia coli strains in patients with chronic pyelonephritis.
    Infection. 1986 May-Jun;14(3):145-50 PMID: 2874114
  15. Expression of P, type-1, and type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection.
    J Infect Dis. 1987 Oct;156(4):567-74 PMID: 2887621
  16. Virulence factors of Escherichia coli in urinary isolates from pregnant women.
    J Infect Dis. 1987 Dec;156(6):870-7 PMID: 3316415
  17. Aerobactin production of serotyped Escherichia coli from urinary tract infections.
    Med Microbiol Immunol. 1988;177(1):9-14 PMID: 3277028
  18. Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli.
    Infect Immun. 1989 Feb;57(2):303-13 PMID: 2563254
  19. Untreated asymptomatic bacteriuria in girls: II--Effect of phenoxymethylpenicillin and erythromycin given for intercurrent infections.
    BMJ. 1989 Apr 1;298(6677):856-9 PMID: 2497823
  20. Frequency and organization of pap homologous DNA in relation to clinical origin of uropathogenic Escherichia coli.
    J Infect Dis. 1990 Mar;161(3):518-24 PMID: 1968935
  21. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.
    Am J Med. 2002 Jul 8;113 Suppl 1A:5S-13S PMID: 12113866
  22. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli.
    Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17020-4 PMID: 12471157
  23. Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens.
    Urology. 2003 May;61(5):1059-62 PMID: 12736047
  24. Intracellular bacterial biofilm-like pods in urinary tract infections.
    Science. 2003 Jul 4;301(5629):105-7 PMID: 12843396
  25. The host response to urinary tract infection.
    Infect Dis Clin North Am. 2003 Jun;17(2):279-301 PMID: 12848471
  26. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.
    J Urol. 2004 Apr;171(4):1682-5 PMID: 15017266
  27. Pathogenic Escherichia coli.
    Nat Rev Microbiol. 2004 Feb;2(2):123-40 PMID: 15040260
  28. PapG-dependent adherence breaks mucosal inertia and triggers the innate host response.
    J Infect Dis. 2004 May 1;189(9):1734-42 PMID: 15116313
  29. Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa.
    Infect Immun. 2004 Jun;72(6):3179-86 PMID: 15155619
  30. Selection footprint in the FimH adhesin shows pathoadaptive niche differentiation in Escherichia coli.
    Mol Biol Evol. 2004 Jul;21(7):1373-83 PMID: 15044596
  31. Transcriptome of uropathogenic Escherichia coli during urinary tract infection.
    Infect Immun. 2004 Nov;72(11):6373-81 PMID: 15501767
  32. Estimation of residual urine volume with 131 I-hippuran.
    Br J Urol. 1968 Apr;40(2):196-201 PMID: 5653009
  33. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains.
    Infect Immun. 1990 May;58(5):1281-9 PMID: 2182540
  34. Significance of asymptomatic bacteriuria in spinal cord injury patients on condom catheter.
    J Urol. 1990 May;143(5):979-80 PMID: 2329615
  35. Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae.
    Infect Immun. 1990 Jun;58(6):1995-8 PMID: 1971261
  36. Virulence factors in Escherichia coli urinary tract infection.
    Clin Microbiol Rev. 1991 Jan;4(1):80-128 PMID: 1672263
  37. Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence.
    Infect Immun. 1991 Sep;59(9):2915-21 PMID: 1879917
  38. A theoretical and experimental analysis of bacterial growth in the bladder.
    Mol Microbiol. 1992 Feb;6(4):555-62 PMID: 1560784
  39. Microbial adhesion and biofilm formation on ureteral stents in vitro and in vivo.
    J Urol. 1992 Nov;148(5):1592-4 PMID: 1433574
  40. Virulence-associated characteristics of Escherichia coli in urinary tract infection: a statistical analysis with special attention to type 1C fimbriation.
    Microb Pathog. 1993 Jul;15(1):65-75 PMID: 7692211
  41. FimH family of type 1 fimbrial adhesins: functional heterogeneity due to minor sequence variations among fimH genes.
    J Bacteriol. 1994 Feb;176(3):748-55 PMID: 7905476
  42. The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract.
    Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):11889-93 PMID: 7991552
  43. Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children.
    J Infect Dis. 1995 Mar;171(3):625-31 PMID: 7876609
  44. Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes.
    J Bacteriol. 1995 Jul;177(13):3680-6 PMID: 7601831
  45. Epithelial cytokine responses and mucosal cytokine networks.
    Trends Microbiol. 1995 Jul;3(7):266-70 PMID: 7551639
  46. Massive gene decay in the leprosy bacillus.
    Nature. 2001 Feb 22;409(6823):1007-11 PMID: 11234002
  47. The development of bacterial biofilms on indwelling urethral catheters.
    World J Urol. 1999 Dec;17(6):345-50 PMID: 10654364
  48. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients.
    J Urol. 2000 Mar;163(3):872-7 PMID: 10687996
  49. Receptor structure for F1C fimbriae of uropathogenic Escherichia coli.
    Infect Immun. 2000 Jun;68(6):3541-7 PMID: 10816509
  50. Bacterial adhesins: function and structure.
    Int J Med Microbiol. 2000 Mar;290(1):27-35 PMID: 11043979
  51. Management of biofilm infections in the urinary tract.
    World J Surg. 2000 Oct;24(10):1193-6 PMID: 11071460
  52. Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli.
    J Infect Dis. 2001 Jan 1;183(1):78-88 PMID: 11106538
  53. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7.
    Nature. 2001 Jan 25;409(6819):529-33 PMID: 11206551
  54. Fimbriae, transmembrane signaling, and cell activation.
    J Infect Dis. 2001 Mar 1;183 Suppl 1:S47-50 PMID: 11171014
  55. Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition.
    FEMS Microbiol Lett. 2006 Sep;262(1):22-30 PMID: 16907735
  56. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli.
    Clin Microbiol Infect. 2006 Oct;12(10):1034-6 PMID: 16961644
  57. Black holes, antivirulence genes, and gene inactivation in the evolution of bacterial pathogens.
    FEMS Microbiol Lett. 2007 Feb;267(1):1-8 PMID: 17233672
  58. Biofilm formation by asymptomatic and virulent urinary tract infectious Escherichia coli strains.
    FEMS Microbiol Lett. 2007 Feb;267(1):30-7 PMID: 17166230
  59. Global gene expression profiling of asymptomatic bacteriuria Escherichia coli during biofilm growth in human urine.
    Infect Immun. 2007 Feb;75(2):966-76 PMID: 17145952
  60. Biofilm exclusion of uropathogenic bacteria by selected asymptomatic bacteriuria Escherichia coli strains.
    Microbiology. 2007 Jun;153(Pt 6):1711-9 PMID: 17526829
  61. In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections.
    Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9630-5 PMID: 8790381
  62. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract.
    Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9827-32 PMID: 8790416
  63. Urodynamic factors influence the duration of Escherichia coli bacteriuria in deliberately colonized cases.
    J Urol. 1998 Jun;159(6):2057-62 PMID: 9598517
  64. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.
    Science. 1998 Nov 20;282(5393):1494-7 PMID: 9822381
  65. Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria.
    Infect Immun. 1999 Jan;67(1):429-32 PMID: 9864249
  66. Bacterial biofilms: a common cause of persistent infections.
    Science. 1999 May 21;284(5418):1318-22 PMID: 10334980
  67. THE MATHEMATICAL RELATIONSHIP AMONG URINARY FREQUENCY, RESIDUAL URINE, AND BACTERIAL GROWTH IN BLADDER INFECTIONS.
    Invest Urol. 1965 Mar;2:468-73 PMID: 14261788
  68. Bacterial interference for prevention of urinary tract infection: a prospective, randomized, placebo-controlled, double-blind pilot trial.
    Clin Infect Dis. 2005 Nov 15;41(10):1531-4 PMID: 16231269
  69. The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine.
    Infect Immun. 2006 Jan;74(1):615-24 PMID: 16369018
  70. Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen.
    Infect Immun. 2006 Jan;74(1):781-5 PMID: 16369040
  71. Global gene expression profiling of the asymptomatic bacteriuria Escherichia coli strain 83972 in the human urinary tract.
    Infect Immun. 2006 Jun;74(6):3565-75 PMID: 16714589
  72. Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae.
    Microbiology. 2006 Jun;152(Pt 6):1799-806 PMID: 16735742
  73. Asymptomatic bacteriuria: review and discussion of the IDSA guidelines.
    Int J Antimicrob Agents. 2006 Aug;28 Suppl 1:S42-8 PMID: 16829049
  74. Bacterial interference--is deliberate colonization with Escherichia coli 83972 an alternative treatment for patients with recurrent urinary tract infection?
    Int J Antimicrob Agents. 2006 Aug;28 Suppl 1:S26-9 PMID: 16843646
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
DOI
10.1128/IAI.01730-06
Email
pkl@biocentrum.dtu.dk
Published
2007-08-00
Epub
2007-00-14
Pages
3688-95
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC1951988
Subset
IM
External Links
PubMed source DOI: 10.1128/IAI.01730-06 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2